Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1CNS 1

Conditions

Lymphoma 74Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Non-Hodgkin 54Lymphoma, Mantle-Cell 40Lymphoma, Follicular 37Hodgkin Disease 36Lymphoma, Large-Cell, Immunoblastic 26Burkitt Lymphoma 25Leukemia, Lymphocytic, Chronic, B-Cell 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, B-Cell, Marginal Zone 15Leukemia 10Recurrence 9Lymphoma, B-Cell 9Lymphoma, T-Cell 8Multiple Myeloma 7Waldenstrom Macroglobulinemia 6Neoplasms, Plasma Cell 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, T-Cell, Peripheral 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Myeloid, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Dendritic Cell Sarcoma, Interdigitating 4Congenital Abnormalities 4Myelodysplastic Syndromes 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myeloid, Accelerated Phase 3Blast Crisis 3

Interventions

Cyclophosphamide 2tanespimycin 1entinostat 1Vorinostat 1Thiotepa 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Indinavir 1Filgrastim 1Fentanyl 1Etoposide 1Docetaxel 1Cryosurgery 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Carmustine × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡